Press Releases

• March 14, 2023
  

  C-Path Welcomes BioCentury Inc. Co-Founder Bernstein to Board of Directors

  TUCSON, Ariz., March 14, 2023 — Critical Path Institute (C-Path) today announced the appointment of Karen Bernstein, Ph.D., to its Board of Directors. Bernstein will help steer the strategic vision and mission of the nonprofit organization as it continues to accelerate the path to a healthier world.

• February 17, 2023
  

  C-Path Stands with Bruce Willis, Neurodegenerative Disease Community After FTD Diagnosis

  C-Path and its members stand with Bruce Willis and his family as they bravely revealed the difficult news of his Frontotemporal Degeneration (FTD) diagnosis yesterday. Also known as frontotemporal degeneration, the Association for Frontotemporal Degeneration (AFTD) defines FTD as a group of brain disorders caused by degeneration of the frontal and/or temporal lobes of the...
• February 15, 2023
  

  Airway Therapeutics Joins C-Path’s International Neonatal Consortium

  C-Path today announced that Airway Therapeutics, Inc., (“Airway”) a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases, has become a member of its International Neonatal Consortium (INC)

• January 25, 2023
  

  C-Path Receives Letter of Support from EMA on Duchenne Muscular Dystrophy Clinical Trial Simulation Platform

  C-Path today announced that the European Medicines Agency (EMA) has issued a letter of support for the Duchenne Regulatory Science Consortium’s (D-RSC) Model-based Clinical Trial Simulation Platform for Duchenne Muscular Dystrophy (DMD).

• December 20, 2022
  

  C-Path’s Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System

  The iBox Scoring System is available for use in kidney transplant clinical trials as a novel secondary endpoint prognostic for allograft loss.